On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2012: Volume 17/ Issue 46 Article 5
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 17, Issue 46, 15 November 2012
EMCDDA publishes 2012 report on the state of the drugs problem in Europe
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. EMCDDA publishes 2012 report on the state of the drugs problem in Europe. Euro Surveill. 2012;17(46):pii=20315. Available online:

Today, 15 November 2012, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon, published its 17th annual report on the state of the drugs problem in Europe.

In this year’s report, the Centre raises concerns over a complex stimulant market with a diversity of powders and pills used today. While cocaine, ecstasy and amphetamines continue to be the main stimulants used, they are now competing with a growing number of emerging synthetic drugs, such as cathinones, one of the largest groups of new drugs being reported in Europe today.

The report also shows a decline in heroin use. While heroin-related problems continue, at lower levels, the Centre states that ‘we may now be moving into a new era in which heroin will play a less central role in Europe’s drugs problem’.

A chapter dedicated to drug-related infectious diseases and drug-related deaths stresses that regardless of the substance used, drug injecting continues to be an important vehicle for the transmission of infectious diseases, including HIV and hepatitis C, with new HIV outbreaks recently experienced by some European countries underlining the importance of maintaining effective public health response in this area.

The EMCDDA annual report 2012 is available for downloading in 22 languages on the Centre’s website:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.